Skip to main content

Table 6 Effects of the study drugs on blood pressure (mmHg), HR (bpm) and plasma creatinine (μmol/L)

From: Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels

Parameters High BNP group Extra-high BNP group
  Dobutamine (n = 30) rhBNP (n = 28) Dobutamine (n = 23) rhBNP (n = 23)
  Baseline 5 Days Baseline 5 Days Baseline 5 Days Baseline 5 Days
SBP 119.3 ± 12.7 121.3 ± 12.0 122.9 ± 11.9 115.4 ± 12.4** 114.8 ± 11.9 116.0 ± 12.5 118.6 ± 13.0 113.2 ± 13.2**
DBP 72.4 ± 6.8 74.3 ± 5.3 73.5 ± 7.7 69.6 ± 7.9** 70.7 ± 6.7 71.8 ± 6.6 71.9 ± 6.5 68.7 ± 6.6**
HR 77.6 ± 12.5 80.3 ± 13.1 81.8 ± 11.1 83.9 ± 11.5 83.2 ± 13.9 85.7 ± 13.0 82.3 ± 12.4 84.6 ± 9.3
Cr 84.4 ± 29.8 79.3 ± 20.4 78.5 ± 31.9 80.9 ± 26.3 95.4 ± 24.4 90.3 ± 23.3 98.6 ± 30.1 105.5 ± 32.9
  1. Abbreviations: HR heart rate. Other abbreviations are same as in Table 1 and Table 2. Values are mean ± SD. **P < 0.01 (paired t- test) versus baseline.